Urology therapeutics Market Research Reports

"...... from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also included such as United States, China, Japan, India, ......"

"...... the urinary bladder (mainly detrusor muscle), resulting in a sudden, uncontrollable urge to urinate (called urinary urgency) with or without actual leakage of urine, even thought only small amounts of urine may be in the bladder. This report ......"

"...... nd market growth of the Urinary Tract Infection Treatment industry, and breaks down according to the type, application, and consumption area of Urinary Tract Infection Treatment. The report also conducted a PESTEL analysis of the industry to study th......"

"...... brilliant attempt to unveil key opportunities available in the global Nifuratel market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size......"

"...... f the Crigler-Najjar Syndrome (Genetic Disorders) pipeline landscape. Crigler-Najjar syndrome is a severe condition characterized by high levels of a toxic substance called bilirubin in the blood (hyperbilirubinemia). Symptoms include ye......"

"...... r treatment market. Market Analysis and Insights: Global Overactive Bladder Treatment Market The global Overactive Bladder Treatment market size is projected to reach US$ 6683.2 million by 2027, from US$ 5434 million in 2020, at......"

"...... rom US$ 4901 million in 2020. Over the next five years the Overactive Bladder Treatment market will register a 3.1% CAGR in terms of revenue, the global market size will reach US$ 5540.2 million by 2026. This report presents a comprehe......"

"...... sis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Urologicals - Hormonal Therapy - Gynecological - Anti-infectives ......"

"...... yelinase Deficiency (Niemann-Pick Disease) Type B pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B, complete with a......"

"...... mprehensive information on the therapeutics under development for Glycogen Storage Disease 1A, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also co......"